ICON PUBLIC LIMITED COMPANY
Ownership & governance
Executives 5Directors 10Avg age 59Avg tenure 6.3y
BB
Barry Balfe
Chief Executive Officer
Age 48Since 2025-09-30Profile →
+14
Executives5
BB
Barry Balfe→
Chief Executive Officer
Age 48Since 2025-09-30
NC
Nigel Clerkin→
Director of Finance/CFO
Age 53Since 2024-09-30
UB
Ute Berger→
Chief Tech/Sci/R&D Officer
—Since 2025-05-31
TO
Tom O'Leary→
Chief Tech/Sci/R&D Officer
—Since 2013-06-30
DC
Diarmaid Cunningham→
Chief Administrative Officer
Age 51Since 2016-06-30
Board of directors10
JC
John Climax→
Chairman
Age 73Since 2002-10-31
CM
Ciaran Murray→
Chairman
Age 63Since 2017-02-28
EM
Eugene McCague→
Director/Board Member
Age 67Since 2017-10-03
RM
Rónán Murphy→
Director/Board Member
Age 68Since 2016-10-17
JO
Julie O'Neill→
Director/Board Member
Age 60Since 2019-07-22
LG
Linda Grais→
Director/Board Member
Age 69Since 2021-06-30
AW
Anne Michelle Whitaker→
Director/Board Member
Age 58Since 2024-07-22
BB
Barry Balfe→
Director/Board Member
Age 48Since 2025-09-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Artisan Partners Holdings LP | 10.81 % | 8,278,945 |
| Wellington Trust Co., NA | 7.723 % | 5,913,037 |
| Harris Associates LP | 5.683 % | 4,351,317 |
| Fidelity Management & Research Co. LLC | 5.451 % | 4,174,006 |
| Invesco Advisers, Inc. | 5.066 % | 3,878,869 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Barry Balfe | Chief Executive Officer | 2025-09-30 | - |
| Ciaran Murray | Chairman | 2017-02-28 | - |
| Diarmaid Cunningham | Chief Administrative Officer | 2016-06-30 | - |
| John Climax | Chairman | 2002-10-31 | - |
| Nigel Clerkin | Director of Finance/CFO | 2024-09-30 | - |
| Tom O’Leary | Chief Tech/Sci/R&D Officer | 2013-06-30 | - |
| Ute Berger | Chief Tech/Sci/R&D Officer | 2025-05-31 | - |
| Anne Michelle Whitaker | Director/Board Member | 2024-07-22 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| ICON Clinical Research India Pvt Ltd. | Miscellaneous Commercial Services |
| ICON Clinical Research Ltd. | Miscellaneous Commercial Services |
| Icon Investments (UK) Ltd. | — |
| DOCS Resourcing Ltd. | Medical/Nursing Services |
| ICON Global Treasury Unlimited Co. | Financial Conglomerates |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 185.88Range 155–210Analysts 17
155Mean 185.88210
- Strong buy 1
- Buy 9
- Hold 8
Broker actions40 of 240
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | 175 | 2026-09-18 |
| Citigroup | Maintained | Neutral | 180 | 2026-07-31 |
| Truist Securities | Reiterated | Buy | 209 | 2026-07-31 |
| Truist Securities | Upgrade | Buy | 207 | 2026-06-30 |
| Mizuho | Maintained | Outperform | 190 | 2026-06-26 |
| Citigroup | Maintained | Neutral | 165 | 2026-06-25 |
| BMO Capital | Maintained | Outperform | 187 | 2026-06-25 |
| Barclays | Maintained | Equal-Weight | 175 | 2026-06-25 |
| RBC Capital | Upgrade | Outperform | 185 | 2026-06-25 |
| TD Cowen | Maintained | Buy | 197 | 2026-06-25 |
| JP Morgan | Maintained | Neutral | 155 | 2026-06-25 |
| Evercore ISI Group | Maintained | Outperform | 180 | 2026-06-25 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.